Standardisation within Single Use Systems An Inevitability, But Does It Have To Be Painful?
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
A dominating focus of today’s single use systems in biomanufacturing is the road towards standardisation between equipment suppliers. The absence of standardisation between single use system suppliers is seen as a key discourager to end users despite the many advantages the format provides to the pharma and biotech production process. Advantages to single use system standardisation include the avoidance of costs for system modification and faster implementation. (2)
In regards to the initial shift towards the standardisation objective, in a previous Pharma IQ Jerold Martin, Sr. Vice President, Global Scientific Affairs for Pall Life Sciences, noted: “When single use was initially introduced process design engineers were very enthusiastic about the fact that there was so many options, so many flexibilities. People could design the connections on bags and transfer manifolds, or things like that, in any number of ways, and they liked that, but as single use is maturing, a lot of facilities are concerned about the number of different stock keeping units and part numbers of single use that they have, and so they are seeking to internally standardise what configurations they are going to use to reduce the number of different variants that they’d have to source and inventory. But that’s consolidation. That’s a type of standardisation where you simply decide, I’m going to use transfer manifolds of different links, and things like that that you want to reduce that variation because it’s simpler to manage…”
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.